Ferrum Phos

Ferrosoferric Phosphate


Hyland's Inc.
Human Otc Drug
NDC 54973-4075
Ferrum Phos also known as Ferrosoferric Phosphate is a human otc drug labeled by 'Hyland's Inc.'. National Drug Code (NDC) number for Ferrum Phos is 54973-4075. This drug is available in dosage form of Tablet. The names of the active, medicinal ingredients in Ferrum Phos drug includes Ferrosoferric Phosphate - 6 [hp_X]/1 . The currest status of Ferrum Phos drug is Active.

Drug Information:

Drug NDC: 54973-4075
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Ferrum Phos
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Ferrosoferric Phosphate
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Hyland's Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Tablet
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:FERROSOFERRIC PHOSPHATE - 6 [hp_X]/1
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 06 Dec, 2021
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 23 Dec, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Hyland's Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:91GQH8I5F7
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
54973-4075-150 TABLET in 1 BOTTLE, PLASTIC (54973-4075-1)06 Dec, 2021N/ANo
54973-4075-21 BOTTLE, PLASTIC in 1 CARTON (54973-4075-2) / 100 TABLET in 1 BOTTLE, PLASTIC06 Dec, 2021N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Minor fever, stuffy nose, sore throat

Product Elements:

Ferrum phos ferrosoferric phosphate acacia lactose monohydrate ferrosoferric phosphate ferrosoferric phosphate

Indications and Usage:

Uses ■ temporarily relieves: ■ minor fever ■ stuffy nose ■ sore throat

Warnings:

Warnings sore throat warning if sore throat is severe, persists for more than 2 days, is accompanied or followed by fever, headache, rash, nausea, or vomiting, consult a doctor promptly. stop use and ask a doctor if ■ fever gets worse or lasts more than 3 days. ■ symptoms persist for more than 7 days or worsen. ■ inflammation or infection is present or develops. if pregnant or breastfeeding ask a health professional before use. keep out of reach of children.

Dosage and Administration:

Directions ■ use as directed. ■ adults and children 6 years and over: dissolve 1 tablet under tongue 3 times per day.

Stop Use:

Stop use and ask a doctor if ■ fever gets worse or lasts more than 3 days. ■ symptoms persist for more than 7 days or worsen. ■ inflammation or infection is present or develops.

Package Label Principal Display Panel:

Packaging label - 2 x 50 ct tablet bottles carton hyland's naturals™ cell salt #4 ferrum phos 6x minor fever* stuffy nose* sore throat* 2 x 50 ct bottles quick-dissolving single tablet dose homeopathic carton

Further Questions:

Questions? www.hylands.com or (800) 624-9659


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.